双语新闻：中国敦促消费者停止服用日本小林制药有关产品
China has issued a health alert and suspended online sales of a Japanese dietary supplement.
中国发布了健康警报，并暂停了一种日本膳食补充剂的网上销售。
Health officials have urged consumers to immediately stop taking relevant products of Osaka-based drugmaker Kobayashi Pharmaceutical after five deaths linked to the product containing red yeast rice were reported in Japan.
在日本报道了5起与含有红曲米的产品有关的死亡事件后，卫生官员敦促消费者立即停止服用大阪制药公司小林制药的相关产品。
More than 100 are hospitalized.
超过100人住院治疗。
According to Japanese media reports, the production time of Kobayashi Pharmaceutical Company's "health care products that may be mixed with unknown harmful ingredients" is concentrated in April to October 2023, and the market time is between July and December 2023.
另据日本媒体报道，小林制药公司“可能混有未知有害成分的保健品”的生产时间集中于2023年4月至10月，上市时间在2023年7月至12月之间。
According to CCTV news, on March 28 local time, Japanese Prime Minister Fumio Kishida said that efforts must be made to find out the cause and consider taking all necessary countermeasures in response to the health damage caused by Kobayashi Pharmaceutical's health care products containing red yeast ingredients.
据央视新闻报道，当地时间3月28日，就小林制药公司含红曲成分保健品致消费者健康受损一事，日本首相岸田文雄表示，必须努力查明原因，并考虑采取一切必要对应措施。
中国发布了健康警报，并暂停了一种日本膳食补充剂的网上销售。
Health officials have urged consumers to immediately stop taking relevant products of Osaka-based drugmaker Kobayashi Pharmaceutical after five deaths linked to the product containing red yeast rice were reported in Japan.
在日本报道了5起与含有红曲米的产品有关的死亡事件后，卫生官员敦促消费者立即停止服用大阪制药公司小林制药的相关产品。
More than 100 are hospitalized.
超过100人住院治疗。
According to Japanese media reports, the production time of Kobayashi Pharmaceutical Company's "health care products that may be mixed with unknown harmful ingredients" is concentrated in April to October 2023, and the market time is between July and December 2023.
另据日本媒体报道，小林制药公司“可能混有未知有害成分的保健品”的生产时间集中于2023年4月至10月，上市时间在2023年7月至12月之间。
According to CCTV news, on March 28 local time, Japanese Prime Minister Fumio Kishida said that efforts must be made to find out the cause and consider taking all necessary countermeasures in response to the health damage caused by Kobayashi Pharmaceutical's health care products containing red yeast ingredients.
据央视新闻报道，当地时间3月28日，就小林制药公司含红曲成分保健品致消费者健康受损一事，日本首相岸田文雄表示，必须努力查明原因，并考虑采取一切必要对应措施。
